| Logo Mark MYREXIS, INC.
77731899 07 May 2009 | on 15 Jun 2018 | Pharmaceutical preparations for the prevention and treatment of cancer... Class 005 Class 005 Pharmaceutical Products The stippling is a feature of the mark and does not indicate color. | | | VIVECON MYREXIS, INC.
78871277 27 Apr 2006 | on 04 Nov 2016 | Pharmaceutical preparations for the prevention and treatment of cancer... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type | | | MYREXIS MYREXIS, INC.
77945122 25 Feb 2010 | on 19 Feb 2016 | Pharmaceutical preparations and substances for the treatment of viral,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical products for the prevention and treatment of cancer | | | AZIXA MYREXIS, INC.
78871262 27 Apr 2006 | on 20 Nov 2015 | Pharmaceutical preparations for the prevention and treatment of cancer... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type | | | MYREXIS PHARMACEUTICALS MYREXIS, INC.
77945131 25 Feb 2010 | on 24 Oct 2011 | Pharmaceutical preparations and substances for the treatment of viral,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical products for the prevention and treatment of cancer | | | MYRXS MYREXIS, INC.
77855915 23 Oct 2009 | on 23 May 2011 | Pharmaceutical preparations and substances for the treatment of viral,... Class 005 Class 005 Pharmaceutical Products MYRIAD PHARMACEUTICALS | | | MYRXS PHARMACEUTICALS MYREXIS, INC.
77855926 23 Oct 2009 | on 23 May 2011 | Pharmaceutical preparations and substances for the treatment of viral,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical preparations for the prevention and treatment of cancer | | | LUMEMA MYREXIS, INC.
78871267 27 Apr 2006 | on 10 Aug 2009 | Pharmaceutical preparations for the prevention and treatment of cancer... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type | | | AUTARA MYREXIS, INC.
78871289 27 Apr 2006 | on 10 Aug 2009 | Pharmaceutical preparations for the prevention and treatment of cancer... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type | |